EyePoint Pharmaceuticalsadmin2022-01-15T17:36:29+00:00 Project Description Follow-On Offering Common Stock . $115,000,000 Financial Advisor February 2021 Related Project Details Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInTumblrPinterestVkEmail